Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Rheumatoid Arthritis

  Free Subscription


Articles published in Z Rheumatol

Retrieve available abstracts of 60 articles:
HTML format



Single Articles


    June 2022
  1. MISCHKEWITZ M, Alten R
    [This is how we treat rheumatoid nodules in patients with rheumatoid arthritis in remission].
    Z Rheumatol. 2022 Jun 20. pii: 10.1007/s00393-022-01228.
    PubMed    


  2. ALBRECHT K, Marschall U, Zink A, Callhoff J, et al
    [Prescription frequency of physical therapy for inflammatory rheumatic diseases].
    Z Rheumatol. 2022;81:360-368.
    PubMed     Abstract available


    May 2022
  3. ZHANG G, Liu W, Zhang X, Liu L, et al
    Rescued from desperation: adult-onset Still's disease with life-threatening interstitial lung disease and macrophage activation : Successful treatment by Tocilizumab.
    Z Rheumatol. 2022;81:335-338.
    PubMed     Abstract available


    April 2022
  4. BEIL FT
    [What are the indications for a synovectomy?]
    Z Rheumatol. 2022;81:236-239.
    PubMed     Abstract available


    March 2022
  5. ALBRECHT K, Callhoff J, Strangfeld A
    [Is the prevalence of rheumatoid arthritis truly on the rise?]
    Z Rheumatol. 2022 Mar 31. pii: 10.1007/s00393-022-01192.
    PubMed     Abstract available


  6. MEISSNER Y, Strangfeld A
    [Latest findings from the RABBIT register].
    Z Rheumatol. 2022;81:100-109.
    PubMed     Abstract available


  7. WITTE T
    [Janus kinase inhibitors].
    Z Rheumatol. 2022;81:94-99.
    PubMed     Abstract available


  8. BRAUN J, Richter A, Schmidt C, Baraliakos X, et al
    [Answering epidemiologic rheumatologic questions by cooperation with the large population-based SHIP cohort-findings with relevance for the diagnosis of axial spondyloarthritis (axSpA)].
    Z Rheumatol. 2022;81:150-156.
    PubMed     Abstract available


  9. SHENG Z, Zeng J, Huang W, Li L, et al
    Comparison of therapeutic efficacy and mechanism of paclitaxel alone or in combination with methotrexate in a collagen-induced arthritis rat model.
    Z Rheumatol. 2022;81:164-173.
    PubMed     Abstract available


  10. ALBRECHT K, Kruger K
    [New aspects on treatment of RA].
    Z Rheumatol. 2022;81:91-93.
    PubMed    


    February 2022
  11. LEE YH, Song GG
    Relative remission rates of Janus kinase inhibitors in comparison with adalimumab in patients with active rheumatoid arthritis: a network meta-analysis.
    Z Rheumatol. 2022 Feb 10. pii: 10.1007/s00393-022-01165.
    PubMed     Abstract available


  12. REGEL A, Foll D, Kriegel MA
    [Still's syndrome-similarities and differences between the juvenile and adult forms].
    Z Rheumatol. 2022;81:22-27.
    PubMed     Abstract available


    January 2022
  13. KRUGER K
    [Innovative strategies for treatment of rheumatoid arthritis].
    Z Rheumatol. 2022 Jan 7. pii: 10.1007/s00393-021-01144.
    PubMed     Abstract available


    December 2021
  14. RUFFER N, Tomas NM, Schmiedel S, Jordan S, et al
    [Erratum to: Visceral leishmaniasis mimicking Felty's syndrome in rheumatoid arthritis treated with methotrexate and etanercept].
    Z Rheumatol. 2021 Dec 21. pii: 10.1007/s00393-021-01143.
    PubMed    


  15. WITTE F, Lakomek HJ, Holzinger J, Reinbold WD, et al
    [Polymyalgia rheumatica in 18-fluorodeoxyglucose-positron-emission-tomography/computed tomography : Improvement in diagnostic accuracy and differentiation from rheumatoid arthritis].
    Z Rheumatol. 2021 Dec 1. pii: 10.1007/s00393-021-01133.
    PubMed     Abstract available


  16. KNAB K, Chambers D, Kronke G
    [Protective macrophages : New insights into the role of synovial macrophages in inflammatory joint diseases].
    Z Rheumatol. 2021;80:966-971.
    PubMed     Abstract available


    November 2021
  17. MORF H, Witte T
    [Use of biosimilars in the treatment of rheumatoid arthritis : An overview].
    Z Rheumatol. 2021 Nov 26. pii: 10.1007/s00393-021-01129.
    PubMed     Abstract available


  18. SUNG YK, Lee YH
    The lessebo effect in randomized controlled trials of rituximab in patients with rheumatoid arthritis: a meta-analysis.
    Z Rheumatol. 2021 Nov 10. pii: 10.1007/s00393-021-01126.
    PubMed     Abstract available


  19. KLEINERT S
    [Data analysis in rheumatology practices : Possibilities, limitations, and results].
    Z Rheumatol. 2021;80:827-834.
    PubMed     Abstract available


    October 2021
  20. HAAS JP, Weimann V, Feist E
    [Polyarticular juvenile idiopathic arthritis and rheumatoid arthritis : Common features and differences].
    Z Rheumatol. 2021 Oct 28. pii: 10.1007/s00393-021-01114.
    PubMed     Abstract available


  21. KILTZ U, Buschhorn-Milberger V, Albrecht K, Lakomek HJ, et al
    [Development of quality standards for patients with rheumatoid arthritis for use in Germany].
    Z Rheumatol. 2021 Oct 15. pii: 10.1007/s00393-021-01093.
    PubMed     Abstract available


  22. RUFFER N, Tomas NM, Schmiedel S, Jordan S, et al
    [Visceral leishmaniasis mimicking Felty's syndrome in rheumatoid arthritis treated with methotrexate and etanercept].
    Z Rheumatol. 2021 Oct 11. pii: 10.1007/s00393-021-01105.
    PubMed     Abstract available


  23. LAKOMEK HJ, Rudwaleit M, Hentschel A, Broge B, et al
    [Quality in acute inpatient rheumatology 2021 : Current aspects of the KOBRA quality label of the Association of Rheumatological Acute Care Clinics].
    Z Rheumatol. 2021;80:758-770.
    PubMed     Abstract available


    September 2021
  24. TEKAYA R, Rouached L, Ben Ahmed H, Ben Tekaya A, et al
    Variation of homocysteine levels in rheumatoid arthritis patients: relationship to inflammation, cardiovascular risk factors, and methotrexate.
    Z Rheumatol. 2021 Sep 27. pii: 10.1007/s00393-021-01092.
    PubMed     Abstract available


  25. MAO YM, Liao T, Ye QL, Wu GC, et al
    Increased circulating sclerostin levels in rheumatoid arthritis patients: an updated meta-analysis.
    Z Rheumatol. 2021 Sep 20. pii: 10.1007/s00393-021-01091.
    PubMed     Abstract available


  26. PARDEY N, Zeidler J, Nellenschulte TF, Stahmeyer JT, et al
    [Methotrexate treatment before use of biologics in rheumatoid arthritis : Analysis of guideline compliance].
    Z Rheumatol. 2021 Sep 20. pii: 10.1007/s00393-021-01086.
    PubMed     Abstract available


    July 2021
  27. SUNG YK, Lee YH
    Placebo and nocebo responses in randomized controlled trials of non-tumor necrosis factor biologics and Janus kinase inhibitors in patients with active rheumatoid arthritis showing insufficient response to tumor necrosis factor inhibitors: A meta-anal
    Z Rheumatol. 2021 Jul 9. pii: 10.1007/s00393-021-01047.
    PubMed     Abstract available


  28. LEE YH, Song GG
    Comparative efficacy and safety of infliximab and its biosimilars in patients with rheumatoid arthritis presenting an insufficient response to methotrexate : A network meta-analysis.
    Z Rheumatol. 2021 Jul 6. pii: 10.1007/s00393-021-01040.
    PubMed     Abstract available


  29. HO LEE Y, Gyu Song G
    Comparative efficacy and safety of tumor necrosis factor inhibitors and their biosimilars in patients with rheumatoid arthritis having an insufficient response to methotrexate : A network meta-analysis.
    Z Rheumatol. 2021 Jul 5. pii: 10.1007/s00393-021-01041.
    PubMed     Abstract available


    June 2021
  30. CHRISTENN M
    [Immunogenicity and safety of high dose vs. standard dose of inactivated influenza vaccine in patients with rheumatoid arthritis].
    Z Rheumatol. 2021 Jun 25. pii: 10.1007/s00393-021-01030.
    PubMed    


  31. VALOR-MENDEZ L, Manger B, Schett G, Kleyer A, et al
    [Severe Hepatitis E virus infection in a patient with rheumatoid arthritis treated with baricitinib].
    Z Rheumatol. 2021 Jun 7. pii: 10.1007/s00393-021-01020.
    PubMed     Abstract available


  32. SIEROCINSKI E, Angelow A, Mainz A, Walker J, et al
    [Patient safety in the treatment of rheumatic diseases : Laboratory monitoring in methotrexate treatment].
    Z Rheumatol. 2021;80:418-424.
    PubMed     Abstract available


    May 2021
  33. LEE YH, Song GG
    Comparative efficacy and safety of adalimumab biosimilars and adalimumab in patients with rheumatoid arthritis presenting an insufficient response to methotrexate: a network meta-analysis.
    Z Rheumatol. 2021 May 17. pii: 10.1007/s00393-021-01013.
    PubMed     Abstract available


    April 2021
  34. ARTZT B, Arndt M, Wickler B, Rehart S, et al
    [Gigantic prepatellar "tumor" in rheumatoid arthritis-a case report].
    Z Rheumatol. 2021 Apr 30. pii: 10.1007/s00393-021-01010.
    PubMed     Abstract available


  35. ALBRECHT K, Zink A
    [If smoking, then also drinking? : New aspects on the influence of alcohol and smoking on the risk for rheumatoid arthritis].
    Z Rheumatol. 2021 Apr 20. pii: 10.1007/s00393-021-01004.
    PubMed    


  36. HARTUNG W, Sewerin P, Ostendorf B
    [Sports and exercise therapy in inflammatory rheumatic diseases].
    Z Rheumatol. 2021;80:251-262.
    PubMed     Abstract available


    March 2021
  37. KEYSSER G
    [Safety aspects of the treatment with glucocorticoids for rheumatoid arthritis].
    Z Rheumatol. 2021 Mar 11. pii: 10.1007/s00393-021-00972.
    PubMed     Abstract available


  38. FIEHN C
    [Glucocorticoid-free and low-dose glucocorticoid treatment of rheumatoid arthritis].
    Z Rheumatol. 2021 Mar 10. pii: 10.1007/s00393-021-00973.
    PubMed     Abstract available


  39. SUNG YK, Lee YH
    Placebo and nocebo responses in randomized controlled trials of Janus kinase inhibitor monotherapy for rheumatoid arthritis : A meta-analysis.
    Z Rheumatol. 2021 Mar 9. pii: 10.1007/s00393-021-00969.
    PubMed     Abstract available


    December 2020
  40. CHEN LJ, Zhou YJ, Wen ZH, Tian F, et al
    Efficacy and safety of iguratimod combined with methotrexate vs. methotrexate alone in rheumatoid arthritis : A systematic review and meta-analysis of randomized controlled trials.
    Z Rheumatol. 2020 Dec 21. pii: 10.1007/s00393-020-00944.
    PubMed     Abstract available


  41. MEISSNER Y, Milatz F, Callhoff J, Minden K, et al
    [Register and cohort studies : Overview of the most important data sources at the German Rheumatism Research Center].
    Z Rheumatol. 2020;79:983-995.
    PubMed     Abstract available


  42. HOFF P, Walther M, Wesselmann H, Weinerth J, et al
    [Successful treatment of adult Still's disease with tofacitinib in a HIV-2 positive female patient].
    Z Rheumatol. 2020;79:1046-1049.
    PubMed     Abstract available


  43. BUEHRING B, Thomas J, Wittkamper T, Baraliakos X, et al
    [Evaluation of the trabecular bone score (TBS) in routine clinical care of patients with inflammatory rheumatic and non-inflammatory diseases : Correlation with conventional bone mineral density measurement and prevalence of vertebral fractures].
    Z Rheumatol. 2020;79:1067-1074.
    PubMed     Abstract available


    November 2020
  44. JAGER E
    [Calcium, phosphate and the calcium-sensing receptor : A proinflammatory combination in rheumatoid arthritis].
    Z Rheumatol. 2020 Nov 30. pii: 10.1007/s00393-020-00937.
    PubMed     Abstract available


  45. SCHERER HU
    [Autoantibodies and the autoreactive immune response : There is more to ACPA than ACPA].
    Z Rheumatol. 2020;79:893-897.
    PubMed     Abstract available


    October 2020
  46. ABDA EA, Hassanien MM, Abdelrazek E, Mahran SA, et al
    What can hand sonography and nerve conduction velocity disclose regarding hand dysfunction in rheumatoid arthritis patients?
    Z Rheumatol. 2020 Oct 2. pii: 10.1007/s00393-020-00901.
    PubMed     Abstract available


    September 2020
  47. SAAD RB, Fazaa A, Rouached L, Miladi S, et al
    Sexual dysfunction and its determinants in women with rheumatoid arthritis.
    Z Rheumatol. 2020 Sep 29. pii: 10.1007/s00393-020-00890.
    PubMed     Abstract available


  48. SUNG YK, Lee YH
    Comparative study of the efficacy and safety of tofacitinib, baricitinib, upadacitinib, and filgotinib versus methotrexate for disease-modifying antirheumatic drug-naive patients with rheumatoid arthritis.
    Z Rheumatol. 2020 Sep 24. pii: 10.1007/s00393-020-00889.
    PubMed     Abstract available


  49. SCHWARZE M, Fieguth V, Schuch F, Sandner P, et al
    [Disease-related knowledge acquisition through structured patient information in rheumatoid arthritis (StruPI-RA) : First results of the StruPI-RA study in Germany].
    Z Rheumatol. 2020 Sep 14. pii: 10.1007/s00393-020-00871.
    PubMed     Abstract available


  50. THIELE T, Seeliger T, Witte T, Sander B, et al
    [Severe polyneuropathy in primary Sjogren's syndrome : Sjogren's syndrome should be considered in patients with motor neuropathy].
    Z Rheumatol. 2020;79:707-709.
    PubMed     Abstract available


  51. FOLL D, Wittkowski H, Hinze C
    [Still's disease as biphasic disorder : Current knowledge on pathogenesis and novel treatment approaches].
    Z Rheumatol. 2020;79:639-648.
    PubMed     Abstract available


    August 2020
  52. STEINCHEN N, Muller-Ladner U, Lange U
    [Biological therapy after COVID-19 infection : No reactivation of a COVID-19 infection with positive SARS-CoV-2 antibody status under biological therapy].
    Z Rheumatol. 2020;79:574-577.
    PubMed     Abstract available


  53. WITTE T
    [Longstanding Sjogren's syndrome without heightened risk of lymphoma].
    Z Rheumatol. 2020;79:571-573.
    PubMed    


    June 2020
  54. BEIDER S, Flohr S, Gehlert S, Witte T, et al
    [Association of physical activity with fatigue and functional capacity in patients with rheumatoid arthritis].
    Z Rheumatol. 2020 Jun 25. pii: 10.1007/s00393-020-00830.
    PubMed     Abstract available


  55. SCHNEIDER M, Baseler G, Funken O, Heberger S, et al
    [Management of early rheumatoid arthritis : Interdisciplinary guideline].
    Z Rheumatol. 2020;79.
    PubMed    


    May 2020
  56. BLUML S
    [Erratum to: Biologicals and small molecules for rheumatoid arthritis].
    Z Rheumatol. 2020 May 15. pii: 10.1007/s00393-020-00817.
    PubMed    


  57. LEE YH, Song GG
    Comparative efficacy and safety of tofacitinib, baricitinib, upadacitinib, and filgotinib in active rheumatoid arthritis refractory to biologic disease-modifying antirheumatic drugs.
    Z Rheumatol. 2020 May 4. pii: 10.1007/s00393-020-00796.
    PubMed     Abstract available


  58. HOYER BF
    [New treatments for systemic lupus erythematosus].
    Z Rheumatol. 2020;79:342-350.
    PubMed     Abstract available


  59. MUCKE J, Dusing C, Chehab G, Schneider M, et al
    [Treat to target in systemic lupus erythematosus].
    Z Rheumatol. 2020;79:351-358.
    PubMed     Abstract available


    April 2020
  60. ALTEN R, Mischkewitz M, Stefanski AL, Dorner T, et al
    [Janus kinase inhibitors : State of the art in clinical use and future perspectives].
    Z Rheumatol. 2020;79:241-254.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: